Dividend investing has long rewarded patient investors. Data shows that from 1998 to 2018, high-yield dividend stocks posted ...
Qualys offers a 9% upside with a $150 price target. Learn about QLYS stock about its strong margins, share buybacks, and ...
As shown, with Crexendo’s levered FCF margin of 13.2% and its current WACC, the stock still has ample upside potential.
The offering of shares at a low price of $1.70, combined with pre-funded warrants, might signal a lack of investor confidence or perceived value in the company’s stock. The need for shareholder ...
Robinhood signaled there's still room to grow its crypto offering, including by adding more tradeable tokens and ...
Investors in AST stock today should prepare themselves for at least another 37%-worth of stock dilution before this company ...
However, investors weren't as happy about Datadog's projections for 2025. Full-year revenue of $3.175 billion to $3.195 billion would represent a slowdown in growth to between 18% and 19%. Moreover, ...
The Company intends to grant the underwriters a 30-day option to purchase additional shares of its common stock. In connection with the offering, the Company's common stock has been approved for ...
To offer further encouragement, Dame Emma Walmsley, the company’s chief, offered a more optimistic outlook than expected for ...
SEBI officials, however, said investors in Assam need to be wary of fraudsters offering higher returns from stock trading. They said many investors, who were not too clued into the way the stock ...
Mustang Bio announced a public offering of 2.65 million shares at $3.01 each, aiming to raise approximately $8 million. Mustang Bio, Inc. has announced the pricing of a public offering of ...
par value $0.0001 per share ("Preferred Shares") to certain accredited investors in a non-brokered private placement. The Offering raised net cash proceeds of approximately $2.9 million (after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results